When is vitamin D contraindicated in dialysis patients?

Seminars in Dialysis

Volumn 22, Issue 3, 2009, Pages 249-251

  Khosla, Neenoo ^a   Sprague, Stuart M ^a  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE; VITAMIN; VITAMIN D;

ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; DRUG CONTRAINDICATION; HUMAN; METHODOLOGY; PROGNOSIS; RENAL REPLACEMENT THERAPY; RISK FACTOR; SECONDARY HYPERPARATHYROIDISM; VITAMIN D DEFICIENCY;

HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; PARATHYROID HORMONE; PROGNOSIS; RENAL DIALYSIS; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 67649625315     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2009.00567.x     Document Type: Article

References (25)

1. National Kidney Foundation : K/DOQI clinical practice guidelines for bone mineral metabolism and disease in chronic kidney disease. Am J Kidney Dis 42 (Suppl. 3 S1, 2003
2. Palmer SC, McGregor DO, Macaskill P, Craig JC, Elder GJ, Strippoli GF : Meta-analysis: vitamin D compounds in chronic kidney disease. Ann Intern Med 147 : 840 853, 2007 (Pubitemid 351664426)
3. Norman AW : From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 88 (Suppl. 2 491S 499S, 2008
4. Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo CA Jr., Tonelli M, Thadhani R : Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 72 : 1004 1013, 2007 (Pubitemid 47530570)
5. Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernán MA, Camargo CA Jr., Thadhani R : Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 16 : 1115 1125, 2005 (Pubitemid 41710323)
6. Teng M, Wolf M, Lowrie E, Ofsthun N, Lazarus JM, Thadhani R : Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 349 : 446 456, 2003 (Pubitemid 36910023)
7. Tentori F, Hunt WC, Stidley CA, Rohrscheib MR, Bedrick EJ, Meyer KB, Johnson HK, Zager PG : Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int 70 : 1858 1865, 2006 (Pubitemid 44684819)
8. Wolf M, Betancourt J, Chang Y, Shah A, Teng M, Tamez H, Gutierrez O, Camargo CA Jr., Melamed M, Norris K, Stampfer MJ, Powe NR, Thadhani R : Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol 19 : 1379 1388, 2008
9. 3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat. Am J Physiol Renal Physiol 286 : F526 F533, 2004
10. 3 regulation of cardiac myocyte proliferation and hypertrophy. Am J Physiol 272 : H1751 H1758, 1997
11. 3 in the pancreas. Cell Tissue Res 209 : 515 520, 1980
12. 3 is a negative regulator of renin-angiotensin system. J Clin Invest 110 : 229 238, 2002 (Pubitemid 34787360)
13. Nyomba BL, Bouillon R, De Moor P : Influence of vitamin D status on insulin secretion and glucose tolerance in the rabbit. Endocrinology 115 : 191 197, 1984 (Pubitemid 14086809)
14. 2, potentiate the effects of ionizing radiation on human prostate cancer cells. Br J Cancer 89 : 746 753, 2003 (Pubitemid 37076184)
15. 2: antitumor activity against leukemia, myeloma, and colon cancer cells. J Natl Cancer Inst 95 : 896 905, 2003 (Pubitemid 36833881)
16. Kristal-Boneh E, Froom P, Harari G, Ribak J : Association of calcitriol and blood pressure in normotensive men. Hypertension 30 : 1289 1294, 1997 (Pubitemid 27476193)
17. Need AG, O'Loughlin PD, Horowitz M, Nordin BE : Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women. Clin Endocrinol (Oxf) 62 : 738 741, 2005 (Pubitemid 40825945)
18. Scragg R, Sowers M, Bell C : Serum 25-hydroxyvitamin D, diabetes and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 27 : 2813 2818, 2004 (Pubitemid 39565042)
19. Garland C, Shekelle RB, Barrett-Connor E, Criqui MH, Rossof AH, Paul O : Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 1 : 307 309, 1985 (Pubitemid 15157126)
20. London GM, Guerin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Mëtivier F : Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 18 : 613 620, 2007 (Pubitemid 46193327)
21. Qunibi WY, Nolan CA, Ayus JC : Cardiovascular calcification in patients with end-stage renal disease: a century old phenomenon. Kidney Int 62 (Suppl S73 S80, 2002
22. Mathew S, Lund RJ, Chaudhary LR, Geurs T, Hruska KA : Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol 19 : 1509 1519, 2008
23. Coyne D, Acharya M, Qiu P, Abboud H, Batlle D, Rosansky S, Fadem S, Levine B, Williams L, Andress DL, Sprague SM : Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD. Am J Kidney Dis 47 : 263 276, 2006 (Pubitemid 43121329)
24. Sprague SM, Llach F, Amdahl M, Taccetta C, Batlle D : Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism. Kidney Int 63 : 1483 1490, 2003 (Pubitemid 36350014)
25. Zisman AL, Hristova M, Ho LT, Sprague SM : Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease. Am J Nephrol 27 : 36 43, 2007 (Pubitemid 46364539)